Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockIT - Software
Computers - Software & Consulting
121 Cr
Low Risk
-1,512.6
17.2
—
14.7
143.90
6.40
Sales CAGR
Profit CAGR
ROE
ROCE
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
iSERA Lifesciences Ltd (COVIDH) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
iSERA Lifesciences Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, iSERA Lifesciences Ltd has traded between a low of ₹6.40 and a high of ₹143.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
iSERA Lifesciences Ltd has a market capitalization of approximately 121.01. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
iSERA Lifesciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -1512.63 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 121.01 Cr, iSERA Lifesciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
iSERA Lifesciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of iSERA Lifesciences Ltd is -1512.63. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The board meeting is scheduled for Monday, April 20, 2026.
Bearish
3
Neutral
8
Bullish
3
Bearish
5
Neutral
24
Bullish
17
Bearish
2
Neutral
16
Bullish
14
Bearish
3
Neutral
8
Bullish
3
Bearish
3
Neutral
8
Bullish
3
Bearish
2
Neutral
16
Bullish
14
Bearish
2
Neutral
16
Bullish
14
Bearish
2
Neutral
16
Bullish
14
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
147.40 | 155 Cr | 47.19 | 6.61 | 0.00 | 10.97 | 10.20 | 6.81 | ||
38.05 | 148 Cr | -9.63 | 2.09 | 0.00 | -20.52 | -11.98 | -10.66 | ||
82.40 | 148 Cr | 10.88 | 1.63 | 0.00 | 37.81 | 44.67 | 21.35 | ||
22.40 | 140 Cr | 14.93 | 1.80 | 2.61 | 14.58 | 19.67 | 11.03 | ||
38.53 | 129 Cr | 8.79 | 2.98 | 0.00 | 25.75 | 33.40 | 29.51 | ||
143.90 | 121 Cr | -1512.63 | 14.67 | 0.00 | 3.15 | 3.39 | -0.57 | ||
61.69 | 113 Cr | 5.17 | 0.74 | 0.00 | 20.80 | 24.32 | 8.50 | ||
| Median: 7 Co. | — | 61.69 | 140 Cr | 8.79 | 2.09 | 0.00 | 14.58 | 19.67 | 8.50 |
AGM/EGM Notice
iSERA Lifesciences Limited published a newspaper public notice for its 34th Annual General Meeting to be held through VC/OAVM on 2026-09-28 at 15:00 (per notice) with e-voting details and dispatch of notice completed.
AGM/EGM Notice
iSERA Lifesciences Ltd notified its 34th AGM for FY2025-26 to be held on 2026-09-29 at 15:00 IST via VC/OAVM. Remote e-voting from 2026-09-26 09:00 to 2026-09-28 17:00. Annual report and notice available online.
